The University of Southampton
University of Southampton Institutional Repository

Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women

Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women
Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women
Background
Persistent infection with human papillomavirus (HPV) type 16 causes the majority of cervical cancers. Genital HPV infection is very common, but neoplastic progression is uncommon. There is an urgent need for biomarkers associated with cervical neoplasia, to enable triage of women who test positive for HPV.

Objectives
To assess the ability of quantitative measurement of HPV16 DNA methylation to separate samples of different cytological and histological grades from young women, among whom rates of HPV infection are high.

Study design
DNA methylation was quantified by pyrosequencing of bisulphite converted DNA from liquid based cytology samples from 234 women (mean age 20.6 years) who tested positive for HPV16 and showed varying degrees of neoplasia. Methylation was assessed at CpGs in the HPV E2 and L1/L2 regions.

Results
The performance of methylation-based classifiers was assessed by ROC curve analyses. The best combination of CpGs (5600 and 5609) achieved AUCs of 0.656 (95% CI = 0.520–0.792) for separation of cytologically normal and severely dyskaryotic samples, and 0.639 (95% CI = 0.547–0.731) for separation of samples with or without high-grade neoplasia (CIN2+/−).

Conclusions
The data are consistent with HPV L1/L2 methylation being a marker of the duration of infection in a specific host. Assessment of HPV DNA methylation is hence a promising biomarker to triage HPV-positive cytology samples, but may have limited utility in young women. Future studies assessing the likely utility of HPV DNA methylation as a potential triage biomarker must take account of women’s age.
1386-6532
Bryant, D.
10ed83e8-8080-4d9c-bba5-df9d4eec3a10
Hibbitts, S.
dc5bb5c9-0925-43e8-85dd-f1f8a0ac3acc
Almonte, M.
455e9a7c-597c-4784-88c6-6c2c029f2560
Tristram, A.
fe20a895-83ec-43e0-b7db-68ca71fae52d
Fiander, A.
57b17dd5-ba65-4252-b56a-d3a3276d74e6
Powell, N.
9caeded2-8573-45a7-9c8c-44f286ce9cb6
Bryant, D.
10ed83e8-8080-4d9c-bba5-df9d4eec3a10
Hibbitts, S.
dc5bb5c9-0925-43e8-85dd-f1f8a0ac3acc
Almonte, M.
455e9a7c-597c-4784-88c6-6c2c029f2560
Tristram, A.
fe20a895-83ec-43e0-b7db-68ca71fae52d
Fiander, A.
57b17dd5-ba65-4252-b56a-d3a3276d74e6
Powell, N.
9caeded2-8573-45a7-9c8c-44f286ce9cb6

Bryant, D., Hibbitts, S., Almonte, M., Tristram, A., Fiander, A. and Powell, N. (2015) Human papillomavirus type 16 L1/L2 DNA methylation shows weak association with cervical disease grade in young women. Journal of Clinical Virology, 66. (doi:10.1016/j.jcv.2015.03.001).

Record type: Article

Abstract

Background
Persistent infection with human papillomavirus (HPV) type 16 causes the majority of cervical cancers. Genital HPV infection is very common, but neoplastic progression is uncommon. There is an urgent need for biomarkers associated with cervical neoplasia, to enable triage of women who test positive for HPV.

Objectives
To assess the ability of quantitative measurement of HPV16 DNA methylation to separate samples of different cytological and histological grades from young women, among whom rates of HPV infection are high.

Study design
DNA methylation was quantified by pyrosequencing of bisulphite converted DNA from liquid based cytology samples from 234 women (mean age 20.6 years) who tested positive for HPV16 and showed varying degrees of neoplasia. Methylation was assessed at CpGs in the HPV E2 and L1/L2 regions.

Results
The performance of methylation-based classifiers was assessed by ROC curve analyses. The best combination of CpGs (5600 and 5609) achieved AUCs of 0.656 (95% CI = 0.520–0.792) for separation of cytologically normal and severely dyskaryotic samples, and 0.639 (95% CI = 0.547–0.731) for separation of samples with or without high-grade neoplasia (CIN2+/−).

Conclusions
The data are consistent with HPV L1/L2 methylation being a marker of the duration of infection in a specific host. Assessment of HPV DNA methylation is hence a promising biomarker to triage HPV-positive cytology samples, but may have limited utility in young women. Future studies assessing the likely utility of HPV DNA methylation as a potential triage biomarker must take account of women’s age.

This record has no associated files available for download.

More information

e-pub ahead of print date: 5 March 2015

Identifiers

Local EPrints ID: 495026
URI: http://eprints.soton.ac.uk/id/eprint/495026
ISSN: 1386-6532
PURE UUID: d0502036-00be-4a3d-ad45-e857d8921afa
ORCID for D. Bryant: ORCID iD orcid.org/0000-0003-3163-608X

Catalogue record

Date deposited: 25 Oct 2024 17:03
Last modified: 26 Oct 2024 01:46

Export record

Altmetrics

Contributors

Author: D. Bryant ORCID iD
Author: S. Hibbitts
Author: M. Almonte
Author: A. Tristram
Author: A. Fiander
Author: N. Powell

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×